Thalidomide in Behcet's disease

被引：27

作者：

Shek, LPC ^{[1
]}

Lim, DLC ^{[1
]}

机构：

[1] Natl Univ Singapore, Dept Paediat, Singapore 119074, Singapore

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2002年 / 56卷 / 01期

关键词：

Behcet's disease; review; thalidomide;

D O I：

10.1016/S0753-3322(01)00154-8

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Behcet's disease is a chronic relapsing multisystem disease of unknown aetiology. It has a relapsing cyclical course, and is characterized by the triad of aphthous stomatitis, genital ulcerations and uveitis. There is familial and geographical clustering of cases, especially around the Mediterranean, the Middle East and East Asia. The condition is uncommon, but lesions sometimes are recalcitrant and can be debilitating to the affected individual. The treatment of Behcet's currently involves the use of steroids, immunomodulaters and immunosuppressives. Thalidomide has been used in cases of Behcet's disease with some success. This review will discuss Behcet's disease and the current information we have about using thalidomide for its treatment. (C) 2002 Editions scientifiques et medicales Elsevier SAS.

引用

页码：31 / 35

页数：5

共 48 条

[11] Azathioprine in Behcet's syndrome - Effects on long-term prognosis [J].

Hamuryudan, V ;

Ozyazgan, Y ;

Hizli, N ;

Mat, C ;

Yurdakul, S ;

Tuzun, Y ;

Senocak, M ;

Yazici, H .

ARTHRITIS AND RHEUMATISM, 1997, 40 (04) :769-774

[12] Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial [J].

Hamuryudan, V ;

Mat, C ;

Saip, S ;

Ozyazgan, Y ;

Siva, A ;

Yurdakul, S ;

Zwingenberger, K ;

Yazici, H .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :443-+

[13]

HAMZA M, 1982, NOUV PRESSE MED, V11, P1080

[14] TREATMENT OF BEHCETS-DISEASE WITH THALIDOMIDE [J].

HAMZA, MH .

CLINICAL RHEUMATOLOGY, 1986, 5 (03) :365-371

[15]

Hirohata T, 1975, Hawaii Med J, V34, P244

[16]

*INT STUD GROUP BE, 1990, LANCET, V225, P1078

[17] THALIDOMIDE EFFECTS IN BEHCETS-SYNDROME AND PUSTULAR VASCULITIS [J].

JORIZZO, JL ;

SCHMALSTIEG, FC ;

SOLOMON, AR ;

CAVALLO, T ;

TAYLOR, RS ;

RUDLOFF, HB ;

SCHMALSTIEG, EJ ;

DANIELS, JC .

ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (05) :878-881

[18] Behcet's disease in UK children: clinical features and treatment including thalidomide [J].

Kari, JA ;

Shah, V ;

Dillon, MJ .

RHEUMATOLOGY, 2001, 40 (08) :933-938

[19] Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use [J].

Klausner, JD ;

Freedman, VH ;

Kaplan, G .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (03) :219-223

[20]

KOC Y, 1992, J RHEUMATOL, V19, P402

← 1 2 3 4 5 →